NEWS

Pacific Smiles 11pc holder backs $300m Genesis bid

SYDNEY: It’s Groundhog Day at takeover target Pacific Smiles as shareholders line up ... read more

Drug developer rattles tin for another cash dollop

MELBOURNE: Neurological diseases drug development company Actinogen Medical, capitalised at $95 million on ... read more

Tanarra urges Healius to halt imaging business sale

PERTH: John Wylie’s Tanarra Capital has urged Healius, the pathology giant where it ... read more

Private equity eyes Ramsay Health Care as attractive target

SYDNEY: There’s an increasing amount of talk again about a deal involving Ramsay ... read more